ConductScience.org, home

Trial · NCT01869569

Effect of Pregabalin in Patients With Radiotherapy-related Neuropathic Pain

NCT01869569, Phase 2, Completed, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effect of Pregabalin in Patients With Radiotherapy-related Neuropathic Pain. Trials, record NCT01869569. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01869569

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effect of Pregabalin in Patients With Radiotherapy-related Neuropathic Pain
NCT number
NCT01869569
Status
Completed
Phases
Phase 2
Enrollment
137 participants, actual
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions
Neuropathic Pain
Interventions
Pregabalin, Placebo
First posted
2013-06-05
Last updated
2018-05-25

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumeric Rating Scale (NRS) at week 16week 16The primary efficacy measure is the reduction of NRS from baseline to week 16.
SecondaryBrief Pain Inventory (BPI)week 16The investigators compare the BPI scores at week 16 with those at baseline.
Secondarythe Profile of Mood States-Short Form (POMS-SF)week 16The investigators compare the POMS-SF scores at week 16 with those at baseline.
Secondarythe World Health Organization Quality of Life-BREF (WHOQOL-BREF)week 16The investigators compare the WHOQOL-BREF scores at week 16 with those at baseline.
SecondaryPatient Global Impression of Change (PGIC)week 16
Number of Participants With Treatment Success at the End of Therapy as Measured by the Patient Global Impression of Change (PGIC). A treatment success is defined as Much or Very Much Improved at the Week 16. The PGIC is a 7-point Likert Scale, ranging from very much worse to very much improved
SecondaryClinical Global Impression of Change (CGIC)week 16
Number of Participants With Treatment Success at the End of Therapy Based on Clinical Global Impression of Change (CGIC) . A treatment success is defined as Much or Very Much Improved at the Week 16. The PGIC is a 7-point Likert Scale, ranging from very much worse to very much improve.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
30457920DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01869569

GET https://conductscience.org/api/trials/v1/NCT01869569/registered